expression which parallels primary fibroblast expression levels (4.61 ± 1.8-Fold, 0.027 ± 0.03-Fold, and 0.22 ± 0.17-Fold respectively, p<0.05). dFib cells also showed increased RNA expression of healthy ECM marker genes p<0.05) and Collagen 1 (4.67 ± 1.4-Fold, p<0.05), and Elastin (0.93 ± 0.63-Fold, p<0.01) compared to primary fibroblasts (0.62 ± 0.16-Fold, 2.21 ± 0.86-Fold, and vs. 0.27 ± 0.08-Fold respectively). Proliferating dFib cells further showed differential expression compared to fibroblasts for the scar tissue markers αSMA (0.011 ± 0.006-Fold vs. 0.024 ± 0.012-Fold, p<0.05), Collagen III (0.72 ± 0.2-Fold vs. 0.26 ± 0.11-Fold, p<0.001), and TIMP-1 (2.33 ± 0.63-Fold vs. 0.6 ± 0.18-Fold, p<0.001). Scratch test assays revealed dFib cells maintain smaller defects throughout the healing time course with more cells migrating into the defect. Finally, dFib cells closed the defects significantly faster than primary fibroblasts (32 ± 12.85 hours vs. 64 ± 13.85 hours, p<0.01). Similarly, Masson's Trichrome staining demonstrates smaller defects after 3 weeks of recovery using dFib cells compared to primary fibroblast (1.04 ± 0.13mm 2 vs. 1.29 ± 0.39 mm 2 ) however, this difference did not reach significance (p=0.16).
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CONCLUSION:
ASCs can be differentiated into fibroblast-like cells. These cells produce a robust ECM more similar to healthy skin as opposed to the scar tissue produced by primary cutaneous fibroblasts. These cells migrate into and close in vitro scratch defects more quickly than primary cutaneous fibroblasts and trend toward smaller long-term wounds. ASC differentiated fibroblasts show initial promise for regenerative medicine applications and should be investigated further for optimization in cutaneous wound healing and other therapeutic applications. PURPOSE: Despite decades of experience, tissue expansion (TE) often has high complication rates. Creating a reliable model of skin growth would allow for data-driven optimization of expansion protocols and decrease complication rates if used to plan the expansion. The changes in signaling pathways observed on the transcriptional level in skin under stretch are not well understood. Therefore, we combined mathematical models of skin under stretch with the biological response measured by gene expression levels and with histological assessment of skin structure with the goal of creating a comprehensive multi-scale model of tissue expansion.
METHODS:
Five animal models (Yucatan minipigs) underwent 10 expansion protocols. Each animal was tattooed with 4 grids, 2 of which served as controls. Expanders were placed subcutaneously. The expansion protocols varied regarding volume of fill (60 or 30 cc), timing (1 hour, 24 hours, 3 days, or 7 days prior to expansion), or single versus 2 fills. 3D photography was captured for isogeometric analysis to measure skin growth and stretch. Total RNA from individual biopsies was isolated, gene expression was estimated using RNA-Seq (64 samples), then differences in gene expression were calculated and verified by qRT-PCR.
RESULTS:
Statistically significant changes in gene expression levels correlated to the amount of stretch were obtained for each model. Illustrates the amount of stretch and growth attained prior to sacrifice, as measured by isogeometric analysis for model #3. The apex of the expander (orange) represents the highest stretch and was correlated with the largest changes in gene expression. The genes most dramatically activated by stretch include MMP1, SAA3, ILB1. PDLIM and RHOF were two of the most consistently downregulated genes. The identified genes include well-known responders to the mechanical force (e.g. MMP1 or TNC), as well as completely new genes with no described role in skin adaption to stretch, presenting a new area for further study.
Represents the change in selected genes' expression (as fold change) in the same model, showing the level of expression at the apex (i.e. area of maximal stretch), the side, and base of the expander compared to contralateral controls. These data show correlation between the magnitude of stretch and fold change in gene expression. Subsequent isogeometric analysis provides the tools for determination of the proportion of tissue growth attributable to expansion versus elastic stretch or animal growth.
CONCLUSION:
We have correlated skin growth with changes in gene expression levels and the mathematically calculated mechanical forces applied to each tissue expansion scenario tested. With the addition of histological analysis, we will attain a multi-scale model of skin expansion. Future translational studies will aim to guide tissue expansion protocols in humans to minimize complications and maximize tissue growth. 
